Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive

The New York Times - Business:

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer.

Author: Michael J. de la Merced

This post first appeared in The New York Times - Business. Read the original article.